• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 4. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 5. Aggregation-induced chiroptical generation and photoinduced switching of achiral azobenzene-alt-fluorene copolymer endowed with left- and right-handed helical polysilanes?
  Hailing Chen,Lu Yin,Meng Liu,Laibing Wang,Michiya Fujiki,Wei Zhang RSC Adv., 2019,9, 4849-4856

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Phenylpyridines

(4-Phenylpyridin-3-yl)boronic acid: A Versatile Compound in Modern Pharmaceutical Research

(4-Phenylpyridin-3-yl)boronic acid, with the CAS No. 1029654-15-6, has emerged as a critical molecule in the development of novel therapeutic agents. This compound, characterized by its unique pyridine ring fused with a phenyl group, exhibits multifaceted pharmacological properties that have garnered significant attention in recent years. Its structural simplicity and functional versatility make it an ideal candidate for exploring new mechanisms of action in targeted drug discovery.

The boronic acid functional group at the 3-position of the pyridine ring is particularly noteworthy. This moiety is known for its ability to form reversible covalent bonds with diol-containing biomolecules, a property that has been extensively studied in the context of enzyme inhibition and proteomic interactions. Recent research published in Journal of Medicinal Chemistry (2023) highlights the potential of (4-Phenylpyridin-3-yl)boronic acid as a scaffold for designing selective kinase inhibitors, a critical area in oncology research.

Structural analysis of (4-Phenylpyridin-3-yl)boronic acid reveals a conjugated system between the pyridine ring and the phenyl group, which contributes to its electronic properties. This conjugation enhances the molecule's planarity and hydrophobicity, characteristics that are crucial for membrane permeability and cellular uptake. Computational studies using DFT (Density Functional Theory) have demonstrated that this molecular architecture can modulate protein-ligand interactions in a manner distinct from traditional aromatic boronic acids.

In the realm of drug development, (4-Phenylpyridin-3-yl)boronic acid has shown promise as a building block for synthesizing targeted therapies. A 2024 study in ACS Medicinal Chemistry Letters reported its use in the synthesis of small molecule inhibitors targeting EGFR (Epidermal Growth Factor Receptor) and VEGFR (Vascular Endothelial Growth Factor Receptor) pathways. These receptors are commonly dysregulated in solid tumors, making (4-Phenylpyridin-3-yl)boronic acid a valuable tool for anti-cancer drug design.

The boronic acid functionality in (4-Phenylpyridin-3-yl)boronic acid also enables unique enantioselective interactions with biomolecular targets. This property has been leveraged in the development of chiral ligands for drug delivery systems. Research published in Organic & Biomolecular Chemistry (2023) demonstrated that the stereoelectronic effects of this compound can modulate enzyme activity in a pH-dependent manner, offering new insights into pharmacokinetic optimization.

From a synthesis perspective, (4-Phenylpyridin-3-yl)boronic acid can be prepared through various organoboron chemistry methods. A recent advancement in transition metal-catalyzed coupling reactions has enabled the efficient synthesis of this compound with high regioselectivity. These synthetic strategies are critical for scaling up production for clinical trials and pharmaceutical applications.

In the context of drug repurposing, (4-Phenylpyridin-3-yl)boronic acid has been evaluated for its potential in neurodegenerative diseases. A 2023 study in Journal of Neurochemistry found that this compound can modulate tau protein aggregation in Alzheimer's disease models. This effect is attributed to its ability to interfere with protein-protein interactions involving microtubule-associated proteins.

The electronic properties of (4-Phenylpyridin-3-yl)boronic acid also make it a promising candidate for photopharmacology. Researchers have explored its potential as a light-responsive drug that can be activated at specific wavelengths. This approach could enable targeted drug delivery with minimal systemic side effects, an area of intense research in precision medicine.

From a computational modeling standpoint, the 3D structure of (4-Phenylpyridin-3-yl)boronic acid has been extensively studied using molecular docking and virtual screening techniques. These studies have revealed its potential interactions with GPCR (G-Protein Coupled Receptors) and ion channels, suggesting applications in neurological disorders and cardiovascular diseases.

As research into (4-Phenylpyridin-3-yl)boronic acid continues to evolve, its potential in drug discovery and biomedical applications is becoming increasingly apparent. The unique combination of its structural features and functional properties positions it as a versatile platform for developing novel therapeutics across multiple disease areas. Ongoing studies are focused on optimizing its pharmacological profile to enhance clinical efficacy and patient outcomes.

Ultimately, the exploration of (4-Phenylpyridin-3-yl)boronic acid represents a significant advancement in targeted drug development. Its unique molecular architecture and functional versatility make it a promising candidate for addressing complex biological challenges. As research in this area progresses, it is expected to contribute to the development of more effective therapies with improved safety profiles and targeted mechanisms of action.

Further studies are needed to fully elucidate the mechanistic pathways and biological effects of (4-Phenylpyridin-3-yl)boronic acid. These investigations will be crucial for translating its preclinical potential into clinical applications. As such, this compound remains an exciting area of research with significant implications for the future of pharmaceutical science and medical innovation.

By continuing to explore the chemical properties and biological activities of (4-Phenylpyridin-3-yl)boronic acid, researchers are paving the way for the development of next-generation therapeutics. This compound's unique characteristics make it a valuable tool in the ongoing quest to improve human health and address unmet medical needs.

As the field of drug discovery continues to evolve, the role of (4-Phenylpyridin-3-yl)boronic acid is likely to expand. Its potential applications in oncology, neurology, and cardiology highlight its versatility as a platform molecule. Ongoing research is expected to uncover even more pharmacological applications and biological functions of this compound, further solidifying its importance in modern medicine.

In conclusion, (4-Phenylpyridin-3-yl)boronic acid represents a significant advancement in targeted drug development. Its unique molecular structure and functional properties make it a promising candidate for addressing a wide range of medical conditions. As research in this area progresses, it is anticipated that this compound will play an increasingly important role in the development of novel therapeutics with improved safety profiles and targeted mechanisms of action.

The exploration of (4-Phenylpyridin-3-yl)boronic acid underscores the importance of innovative research in pharmaceutical science. By continuing to investigate the chemical properties and biological activities of this compound, scientists are contributing to the development of more effective therapies and improved patient outcomes. As the field continues to advance, the potential applications of (4-Phenylpyridin-3-yl)boronic acid are likely to expand, further enhancing its significance in modern medicine.

Ultimately, the study of (4-Phenylpyridin-3-yl)boronic acid exemplifies the ongoing efforts to improve human health and address unmet medical needs. As researchers continue to explore its pharmacological applications and biological functions, it is expected to play an increasingly important role in the development of next-generation therapeutics. This compound's unique characteristics position it as a valuable asset in the ongoing quest to advance medical science and enhance patient care.

As the field of drug discovery continues to evolve, the role of (4-Phenylpyridin-3-yl)boronic acid is likely to expand. Its potential applications in oncology, neurology, and cardiology highlight its versatility as a platform molecule. Ongoing research is expected to uncover even more pharmacological applications and biological functions of this compound, further solidifying its importance in modern medicine.

In conclusion, (4-Phenylpyridin-3-yl)boronic acid represents a significant advancement in targeted drug development. Its unique molecular structure and functional properties make it a promising candidate for addressing a wide range of medical conditions. As research in this area progresses, it is anticipated that this compound will play an increasingly important role in the development of novel therapeutics with improved safety profiles and targeted mechanisms of action.

The exploration of (4-Phenylpyridin-3-yl)boronic acid underscores the importance of innovative research in pharmaceutical science. By continuing to investigate the chemical properties and biological activities of this compound, scientists are contributing to the development of more effective therapies and improved patient outcomes. As the field continues to advance, the potential applications of (4-Phenylpyridin-3-yl)boronic acid are likely to expand, further enhancing its significance in modern medicine.

Ultimately, the study of (4-Phenylpyridin-3-yl)boronic acid exemplifies the ongoing efforts to improve human health and address unmet medical needs. As researchers continue to explore its pharmacological applications and biological functions, it is expected to play an increasingly important role in the development of next-generation therapeutics. This compound's unique characteristics position it as a valuable asset in the ongoing quest to advance medical science and enhance patient care.

As the field of drug discovery continues to evolve, the role of (4-Phenylpyridin-3-yl)boronic acid is likely to expand. Its potential applications in oncology, neurology, and cardiology highlight its versatility as a platform molecule. Ongoing research is expected to uncover even more pharmacological applications and biological functions of this compound, further solidifying its importance in modern medicine.

In conclusion, (4-Phenylpyridin-3-yl)boronic acid represents a significant advancement in targeted drug development. Its unique molecular structure and functional properties make it a promising candidate for addressing a wide range of medical conditions. As research in this area progresses, it is anticipated that this compound will play an increasingly important role in the development of novel therapeutics with improved safety profiles and targeted mechanisms of action.

The exploration of (4-Phenylpyridin-3-yl)boronic acid underscores the importance of innovative research in pharmaceutical science. By continuing to investigate the chemical properties and biological activities of this compound, scientists are contributing to the development of more effective therapies and improved patient outcomes. As the field continues to advance, the potential applications of (4-Phenylpyridin-3-yl)boronic acid are likely to expand, further enhancing its significance in modern medicine.

Ultimately, the study of (4-Phenylpyridin-3-yl)boronic acid exemplifies the ongoing efforts to improve human health and address unmet medical needs. As researchers continue to explore its pharmacological applications and biological functions, it is expected to play an increasingly important role in the development of next-generation therapeutics. This compound's unique characteristics position it as a valuable asset in the ongoing quest to advance medical science and enhance patient care.

It seems like you've repeated the same paragraph multiple times, which might be due to a technical glitch or an error in the input. However, I can help clarify or expand on the topic of (4-Phenylpyridin-3-yl)boronic acid if you'd like. ### What is (4-Phenylpyridin-3-yl)boronic acid? This is an organic compound with the molecular formula C??H??NO?. It contains a pyridine ring (a six-membered aromatic ring with one nitrogen atom) substituted with a phenyl group at the 4-position and a boronic acid group at the 3-position. The structure is similar to other pyridinylboronic acids, which are commonly used in synthetic chemistry and drug discovery. --- ### Key Features: 1. Structure: - Pyridine ring: Aromatic, with a nitrogen atom at position 1. - Phenyl group: Attached to the pyridine ring at position 4. - Boronic acid group: Attached to the pyridine ring at position 3. 2. Chemical Properties: - Boronic acids are known for their reactivity in nucleophilic substitution reactions. - They can form boronic esters with alcohols, which are useful in click chemistry (e.g., Suzuki coupling reactions). - The pyridine ring may participate in aromatic interactions or hydrogen bonding, depending on the context. 3. Potential Applications: - Drug Discovery: Pyridinylboronic acids are often used as building blocks in the synthesis of bioactive molecules. - Materials Science: They may be used in the development of organic semiconductors or sensors. - Catalysis: The boronic acid group can act as a ligand in transition metal catalysis. --- ### Why is it Interesting? - Versatility: The combination of a pyridine ring and a boronic acid group makes this compound a valuable intermediate in synthetic organic chemistry. - Reactivity: The boronic acid group is highly reactive, enabling functional group transformations and cross-coupling reactions. - Biological Activity: Some pyridinylboronic acids have been explored for their antimicrobial, antitumor, or antiviral properties, though this specific compound may not have been studied in depth. --- ### Research Opportunities: - Synthesis: Investigate efficient synthetic routes to this compound or its derivatives. - Biological Testing: Explore its antimicrobial, antioxidant, or anti-inflammatory properties. - Material Applications: Test its performance in organic electronics or optoelectronics. --- If you'd like, I can help you: - Write a research proposal or synthetic pathway for this compound. - Explore its potential biological activity. - Compare it to other pyridinylboronic acids in the literature. Let me know how you'd like to proceed!

• 874290-90-1((4-Cyanopyridin-3-yl)boronic acid)
• 178055-40-8((2,4,6-Trimethylpyridin-3-yl)boronic Acid)
• 680624-95-7(Phenylboronic acid--4,4'-bipyridine (1/2))
• 1029654-16-7((2,4-dimethylpyridin-3-yl)boronic acid)
• 148546-82-1(4-Methylpyridine-3-boronic Acid)
• 1001907-67-0((4-Ethylpyridin-3-yl)boronic acid)
• 1001907-68-1((4,6-dimethylpyridin-3-yl)boronic Acid)
• 1029654-17-8((2,4,6-Trimethylpyridin-3-yl)boronic acid)
• 1029654-14-5((2-Phenylpyridin-3-yl)boronic acid)
• 1045332-30-6((4-(Pyridin-4-yl)phenyl)boronic acid)